Related Experiment Video
Updated: Mar 17, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Online E-cigarette Marketing Claims: A Systematic Content and Legal Analysis
Elizabeth G Klein1, Micah Berman1, Natalie Hemmerich1
1Elizabeth G. Klein, Associate Professor, The Ohio State University College of Public Health, Columbus, OH. Micah Berman, Assistant Professor, The Ohio State University College of Public Health and Moritz College of Law, Columbus, OH. Natalie Hemmerich, Postdoctoral Fellow, Center of Excellence in Regulatory Tobacco Science, The Ohio State University College of Public Health, Columbus, OH. Cristen Carlson, MPH, Hamilton County Public Health, Cincinnati, OH. SuSandi Htut, Research Assistant, Center of Excellence in Regulatory Tobacco Science, The Ohio State University College of Public Health, Columbus, OH. Michael Slater, Professor, School of Communication, The Ohio State University College of Arts & Sciences, Columbus, OH.
Objectives:
Electronic nicotine delivery systems (ENDS), or e-cigarettes, are heavily marketed online. The purpose of our study was to perform a systematic identification and evaluation of claims made within ENDS retailer and manufacturer websites, and the legal status of such claims.
Methods:
We employed a systematic search protocol with popular search engines using 6 terms: (1) e-cigarettes; (2) e-cigs; (3) e-juice; (4) e-liquid; (5) e-hookah; and (6) vape pen. We analyzed English-language websites where ENDS are sold for implicit and explicit health-related claims. A legal analysis determined whether such claims are permissible under the US Food and Drug Administration's regulations.
Results:
The vast majority of ENDS manufacturer (N = 78) and retailer (N = 32) websites made at least one health-related claim (77% and 65%, respectively). Modified risk claims and secondhand smoke-related claims were most prevalent, with an average of 2 claims per site.
Conclusions:
Health-related claims are plentiful within ENDS manufacturer and retailer websites. Results demonstrate that these sites focus on potential benefits while minimizing or eliminating information about possible harmful effects of ENDS. These claims are subject to the current regulatory authority by the FDA, and pose a risk of misinforming consumers.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Clinical Trials
There are four phases in a clinical trial. A phase one...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaporization